FDA Approves GSK Lung-Cancer Drug
GSK received U.S. FDA authorization to launch a new medicine for lung cancer.
By Adria CalatayudGSK received U.S. Food and Drug Administration authorization to launch a new medicine for lung cancer, a move that bolsters its efforts to build a franchise in a disease that is the leading cause of cancer death.The U.K. pharmaceutical company said late Tuesday that the FDA grante…